The price hikes are comparable to those seen at the start of previous years. On Jan. 1, 2021, drugmakers increased the price of 629 drugs.
The analysis is based on data from Elsevier’s Gold Standard Drug Database and the CMS State Drug Utilization Database. Data on price increases are still preliminary, as more drugmakers are expected to disclose price increases this month. Drug companies typically roll out price increases twice a year in January and July.
Gilead Sciences, Pfizer, Purdue Pharma and GlaxoSmithKline were among the drugmakers to increase list prices.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.